Clinical characteristics and prognosis of 16 relapsed/refractory B-cell malignancy patients with CAR T-cell-related hyperferritinaemia

Overview of attention for article published in Frontiers in oncology, October 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 10 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 27,028 followers.

RT @CART_Therapy: Clinical characteristics and prognosis of 16 relapsed/refractory B-cell malignancy patients with CAR T-cell-related hyper…

04 Nov 2022

Reply Repost Favourite

Clinical characteristics and prognosis of 16 relapsed/refractory B-cell malignancy patients with CAR T-cell-related hyperferritinaemia #lymphoma #lymsm https://t.co/5TYzhcBMMy

31 Oct 2022

Reply Repost Favourite

Clinical characteristics and prognosis of 16 relapsed/refractory B-cell malignancy patients with CAR T-cell-related hyperferritinaemia: With the success of chimeric antigen receptor-modified (CAR) T-cell therapy for… #oncology https://t.co/phscK0BWzn https

13 Oct 2022

Reply Repost Favourite

New research: Clinical characteristics and prognosis of 16 relapsed/refractory B-cell malignancy patients with CAR T-cell-related hyperferritinaemia: With the success of chimeric antigen receptor-modified (CAR) T-cell therapy for… https://t.co/cKCGXn6qxH #

12 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.